CopyMark Law Group
4.9/5
Drawing for ARM

USPTO serial 88746410

ARM

Reviewed by CopyMark Law Group

Reg. 6214671Status 700Renewal
Filing date
Status date
Registration date
Dec 8, 2020
Examiner
HOPKINS, SARAH COLLEEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen J. Jeffries

Stephen J. Jeffries HOLLAND & KNIGHT LLP800 17th Street, NWSuite 1100WASHINGTON, DC 20006-6801

Goods and services

ClassDescriptionStatusFirst use
035Public advocacy to promote awareness of the importance of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; lobbying services directed to policy makers, namely, promoting the interests of researchers in the field of regenerative medicine, research institutions in the field of regenerative medicine, patient advocacy groups, and companies developing regenerative medicine products, all in the fields of legislation and regulation; arranging and conducting business partnering forums in the field of regenerative medicine; conducting business development conferences in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; all excluding business risk management services in the field of reproductive and primary healthcareACTIVE—
041Conducting workshops and educational conferences in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; educational services, namely, providing non-downloadable webinars in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; all excluding medical teaching and training in the field of reproductive and primary healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 8, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 8, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 8, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 8, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 8, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 8, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2020CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Nov 4, 2020APETASSIGNED TO PETITION STAFF—
Oct 21, 2020ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 25, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 8, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2020DOCKASSIGNED TO EXAMINER—
Jan 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance